Sonidegib for the Treatment of Advanced Basal Cell Carcinoma

Basal cell carcinoma (BCC) accounts for almost 80% of skin cancers, and its healthcare workload burden is substantial within dermatology departments. Although most BCCs are small, well-defined tumors amenable of surgery or conservative procedures, in a small proportion of patients, BCCs can progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancaccio, Gabriella, Pea, Federico, Moscarella, Elvira, Argenziano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662670/
https://www.ncbi.nlm.nih.gov/pubmed/33194718
http://dx.doi.org/10.3389/fonc.2020.582866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662670/
https://www.ncbi.nlm.nih.gov/pubmed/33194718
http://dx.doi.org/10.3389/fonc.2020.582866

Ejemplares similares